CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,784,000 | +49.7% | 1,200,000 | 0.0% | 0.12% | +41.7% |
| Q4 2017 | $1,860,000 | -27.6% | 1,200,000 | 0.0% | 0.08% | -28.8% |
| Q3 2017 | $2,568,000 | -52.7% | 1,200,000 | 0.0% | 0.12% | -56.9% |
| Q2 2017 | $5,424,000 | +50.2% | 1,200,000 | 0.0% | 0.27% | +31.7% |
| Q1 2017 | $3,612,000 | +9.1% | 1,200,000 | 0.0% | 0.21% | -6.3% |
| Q4 2016 | $3,312,000 | -11.7% | 1,200,000 | 0.0% | 0.22% | -5.5% |
| Q3 2016 | $3,751,000 | -38.9% | 1,200,000 | 0.0% | 0.24% | -48.4% |
| Q2 2016 | $6,144,000 | +26.2% | 1,200,000 | +0.8% | 0.46% | +11.5% |
| Q1 2016 | $4,867,000 | -49.6% | 1,190,000 | 0.0% | 0.41% | -44.2% |
| Q4 2015 | $9,651,000 | -3.9% | 1,190,000 | 0.0% | 0.73% | -10.3% |
| Q3 2015 | $10,044,000 | +70.8% | 1,190,000 | +90.4% | 0.82% | +90.0% |
| Q2 2015 | $5,881,000 | +12.4% | 625,000 | +10.6% | 0.43% | -12.3% |
| Q1 2015 | $5,232,000 | – | 565,000 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,241,550 | $7,520,000 | 4.03% |
| Tamarack Advisers, LP | 1,875,000 | $4,350,000 | 2.07% |
| CLOUGH CAPITAL PARTNERS L P | 2,075,663 | $4,816,000 | 0.46% |
| Rock Springs Capital Management LP | 1,200,000 | $2,784,000 | 0.12% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,192,034 | $9,726,000 | 0.08% |
| PUTNAM INVESTMENTS LLC | 3,092,133 | $7,174,000 | 0.02% |
| Renaissance Technologies | 528,913 | $1,227,000 | 0.00% |
| SCOTIA CAPITAL INC. | 19,120 | $44,000 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 51,200 | $118,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 700 | $2,000 | 0.00% |